DOCSLIB.ORG

Molecular Simulations of Disulfide-Rich Venom Peptides With

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Molecular Simulations of Disulfide-Rich Venom Peptides With molecules Review Review Molecular SimulationsSimulations ofof Disulfide-RichDisulfide-Rich VenomVenom Peptides withwith IonIon ChannelsChannels andand MembranesMembranes Evelyne Deplazes 1,2 Evelyne Deplazes 1,2 1 School of Biomedical Sciences, Curtin Health Innovation Research Institute, Curtin University, Perth, 1 School of Biomedical Sciences, Curtin Health Innovation Research Institute, Curtin University, WA 6102, Australia; [email protected] Perth, WA 6102, Australia; [email protected] 2 School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, QLD 4072, 2 School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Australia QLD 4072, Australia Academic Editor: Roberta Galeazzi Academic Editor: Roberta Galeazzi Received: 8 February 2017; Accepted: 24 February 2017; Published: date Received: 8 February 2017; Accepted: 24 February 2017; Published: 27 February 2017 Abstract:Abstract: Disulfide-richDisulfide-rich peptides isolated isolated from from the the venom venom of of arthropods arthropods and and marine marine animals animals are are a arich rich source source of of potent potent and and selective selective modulators modulators of of ion ion channels. channels. This This makes these peptides valuable leadlead moleculesmolecules forfor thethe developmentdevelopment ofof newnew drugsdrugs toto treattreat neurologicalneurological disorders.disorders. Consequently,Consequently, much effort goes into understanding understanding their their mechanis mechanismm of of action. action. This This paper paper presents presents an an overview overview of ofhow how molecular molecular simulations simulations have have been beenused usedto study to studythe interactions the interactions of disulfide-rich of disulfide-rich venom peptides venom peptideswith ion channels with ion channelsand membranes. and membranes. The review The is reviewfocused is on focused the use on of thedocking, use of molecular docking, moleculardynamics dynamicssimulations, simulations, and free energy and free calculations energy calculations to (i) predict to the (i) predictstructure the of structure peptide-channel of peptide-channel complexes; complexes;(ii) calculate (ii) binding calculate free bindingenergies free including energies the including effect of peptide the effect modifications; of peptide modifications; and (iii) study and the (iii)membrane-binding study the membrane-binding properties of properties disulfide-rich of disulfide-rich venom peptides. venom peptides.The review The concludes review concludes with a withsummary a summary and outlook. and outlook. Keywords: venom peptides; ion channels; structure-basedstructure-based drug design;design; molecularmolecular dynamicsdynamics simulations; molecularmolecular docking;docking; molecularmolecular modelling;modelling; freefree energyenergy calculationscalculations 1. Introduction The venomvenom ofof arthropods arthropods (e.g., (e.g., spiders, spiders, scorpions, scorpion ands, and centipedes) centipedes) and and marine marine animals animals (e.g., (e.g., cone snails,cone snails, jellyfishes, jellyfishes, and and sea anemones)sea anemones) are are a rich a rich source source of of biologically biologically active active molecules. molecules. AA majormajor component of these venoms are disulfide-richdisulfide-rich peptides,peptides, also referred to as toxins.toxins. They are typically 10–6010–60 aminoamino acidsacids longlong andand foldfold intointo aa well-definedwell-defined secondarysecondary structurestructure thatthat isis stabilisedstabilised byby multiplemultiple highly conserved disulfidedisulfide bonds [[1].1]. The peptides are highly resistant to extremes of solvents, pH, and temperaturetemperature as as well well as as to to degradation degradation by by proteases. proteases. Figure Figure 11 depicts depicts the the structure structure of of three three examples examples of ofsuch such disulfide-rich disulfide-rich peptides: peptides: Charybdotoxin Charybdotoxin (ChTx) (ChTx) isolated isolated from the from venom the venom of the scorpion of the scorpion Leiurus Leiurusquinquestriatus quinquestriatus hebraeus hebraeus, Stichodactyla, Stichodactyla toxin toxin (ShK) (ShK) from from the the Caribbean Caribbean sea sea anemone anemone Stichodactyla helianthus,, andand Protoxin-IProtoxin-I (ProTx-I)(ProTx-I) fromfrom thethe PeruvianPeruvian green-velvetgreen-velvet tarantulatarantulaThrixopelma Thrixopelma pruriens.pruriens. Figure 1.1: StructuresStructures of of the disulfide-rich disulfide-rich venom peptidespeptides Charybotoxin (ChTx, PDB-id 2CRD), Stichodactyla toxin (ShK, PDB-id 1ROO), and Protoxin-IProtoxin-I (ProTx-I,(ProTx-I, PDB-idPDB-id 2M9L).2M9L). TheThe well-definedwell-defined secondarysecondary structurestructure isis stabilisedstabilised byby oneone oror moremore disulfidedisulfide bondsbonds (yellow).(yellow). Molecules 2017, 22, 362; doi:10.3390/molecules22030362 www.mdpi.com/journal/molecules Molecules 2017, 22, 362; doi:10.3390/molecules22030362 www.mdpi.com/journal/molecules Molecules 2017, 22, 362 2 of 16 Many disulfide-rich venom peptides are potent and selective inhibitors of ion channels and other membrane-bound receptors. Among the most common molecular targets are voltage-gated Molecules 2017, 22, 362 2 of 16 + + 2+ Na (NaV) and K (KV) channels, voltage-sensitive Ca channels, mechanosensitive channels, nicotinic acetylcholineMany disulfide-rich receptors, venom transient peptides receptor are potent potential and selective (TRP) inhibitors cation channels, of ion channels and acid and sensing ion channelsother membrane-bound (ASICs) [2–7 receptors.]. These Among channels the most and common receptors molecular are involved targets are in almostvoltage-gated all aspects Na+ of mammalian(NaV) and physiology K+ (KV) channels, and many voltage-sensitive of them are associated Ca2+ channels, with pathophysiologicalmechanosensitive channels, conditions nicotinic including autoimmuneacetylcholine disorders, receptors, cardiac transient diseases, receptor aspotent wellial as (TRP) neurological cation channels, and musculoskeletal and acid sensing disorders. ion Disulfide-richchannels (ASICs) venom [2–7]. peptides These channels are thus and valuable receptor pharmacologicals are involved in almost tools toall examineaspects of themammalian role of these physiology and many of them are associated with pathophysiological conditions including autoimmune ion channels and receptors in both physiological and pathological conditions [3,8] as well as lead disorders, cardiac diseases, as well as neurological and musculoskeletal disorders. Disulfide-rich molecules to develop new pharmaceuticals [2,4,6,7,9,10]. venom peptides are thus valuable pharmacological tools to examine the role of these ion channels andTranslating receptors venomin both peptidesphysiological into and therapeutically pathological conditions useful molecules [3,8] as well often as lead involves molecules the to use of structure-baseddevelop new andpharmaceuticals rational drug [2,4,6,7,9,10]. design approaches. For this, a detailed understanding of the structural,Translating chemical, venom and biophysical peptides into properties therapeuticall of they useful peptide molecules as well often as its involves interactions the use with of the targetstructure-based protein is required. and rational While drug the design specific approa interactionsches. For betweenthis, a detailed a peptide understanding and a given of the protein are unique,structural, many chemical, peptides and biophysical act via similar properties mechanisms of the peptide as illustrated as well as inits Figureinteractions2. Peptides with the that target protein is required. While the specific interactions between a peptide and a given protein are modulate voltage-gated ion channels (e.g., NaV and KV) can act as pore blockers or gating modifiers. Poreunique, blockers many bind peptides to the solvent-accessibleact via similar mechanisms pore domain as illustrated of the in channel Figure 2. and Peptides prevent that the modulate flow of ions voltage-gated ion channels (e.g., NaV and KV) can act as pore blockers or gating modifiers. Pore (Figure2a). Gating modifiers bind to the membrane-embedded voltage-sensing domains (VSDs) and blockers bind to the solvent-accessible pore domain of the channel and prevent the flow of ions thus alter the kinetics and gating behaviour of the channel (Figure2b). As the VSDs are partially (Figure 2a). Gating modifiers bind to the membrane-embedded voltage-sensing domains (VSDs) and embeddedthus alter into the the kinetics membrane, and gating the activity behaviour of someof the gatingchannel modifiers (Figure 2b). is relatedAs the VSDs to their are ability partially to bind to orembedded partition into into the the membrane, membrane the activity (Figure of2 c)some [ 11 gating,12]. Peptidesmodifiers is that related modulate to their ability ASICs to [bind8] mostly to or act by bindingpartition tointo the the large membrane extracellular (Figure 2c) domain [11,12]. Peptides where putativethat modulate proton-sensing ASICs [8] mostly residues act by binding are located (Figureto the2d). large extracellular domain where putative proton-sensing residues are located (Figure 2d). FigureFigure 2. Schematic 2. Schematic representation representation of of binding binding sites and and mechanisms mechanisms of ofaction action for fordisulfide-rich disulfide-rich venom venom peptidespeptides acting acting on voltage-gatedon voltage-gated ion
Load more

Recommended publications
  • Prospecção De Peptídeos Neuroativos Da Peçonha Da Aranha Caranguejeira Acanthoscurria Paulensis
    UNIVERSIDADE DE BRASÍLIA INSTITUTO DE CIÊNCIAS BIOLÓGICAS Programa de Pós-Graduação em Biologia Animal Laboratório de Toxinologia CAROLINE BARBOSA FARIAS MOURÃO Prospecção de peptídeos neuroativos da peçonha da aranha caranguejeira Acanthoscurria paulensis Brasília 2012 CAROLINE BARBOSA FARIAS MOURÃO Prospecção de peptídeos neuroativos da peçonha da aranha caranguejeira Acanthoscurria paulensis Dissertação apresentada ao Programa de Pós-Graduação em Biologia Animal do Instituto de Ciências Biológicas da Universidade de Brasília como requisito parcial à obtenção do título de Mestre. Orientadora: Dra. Elisabeth Ferroni Schwartz Brasília 2012 À minha mãe, Jaqueline Barbosa, pelo apoio incondicional. À minha família, meu exemplo e suporte. Ao Lucas Caridade, por todo o carinho. À Dra. Elisabeth Schwartz, que proporcionou a realização deste projeto. À Toxinologia, que por envolver áreas tão diversas e complementares, nos permite enjoar temporariamente de uma enquanto nos divertimos com outra. Agradecimentos Primeiramente à minha querida mãe, pelo amor, suporte, incentivo e por ter sempre apoiado minhas escolhas acadêmicas. A toda minha família, pelo exemplo de união, suporte e por estarem sempre presentes. Ao meu primo Pedro Henrique pela ajuda em campo. Ao Lucas Caridade, pelo amor, companheirismo e motivação. Obrigada por fazer tudo parecer mais simples e por ser tão paciente. À Dra. Elisabeth Schwartz, pela orientação, incentivo, sugestões, e pela confiança depositada em mim. Obrigada pela oportunidade. Ao Dr. Carlos Bloch Jr., do Laboratório de Espectrometria de Massas – EMBRAPA Recursos Genéticos e Biotecnologia, por permitir acesso ao laboratório e pelos ensinamentos e sugestões ao longo desses anos. Ao Eder Barbosa, pela amizade e por me auxiliar em todos os sequenciamentos de novo realizados neste trabalho.
    [Show full text]
  • The Andean Tarantulas Euathlus Ausserer, 1875, Paraphysa Simon
    This article was downloaded by: [Fernando Pérez-Miles] On: 05 May 2014, At: 07:07 Publisher: Taylor & Francis Informa Ltd Registered in England and Wales Registered Number: 1072954 Registered office: Mortimer House, 37-41 Mortimer Street, London W1T 3JH, UK Journal of Natural History Publication details, including instructions for authors and subscription information: http://www.tandfonline.com/loi/tnah20 The Andean tarantulas Euathlus Ausserer, 1875, Paraphysa Simon, 1892 and Phrixotrichus Simon, 1889 (Araneae: Theraphosidae): phylogenetic analysis, genera redefinition and new species descriptions Carlos Perafána & Fernando Pérez-Milesa a Universidad de La República, Facultad de Ciencias, Sección Entomología, Iguá 4225, Montevideo, Uruguay Published online: 01 May 2014. To cite this article: Carlos Perafán & Fernando Pérez-Miles (2014): The Andean tarantulas Euathlus Ausserer, 1875, Paraphysa Simon, 1892 and Phrixotrichus Simon, 1889 (Araneae: Theraphosidae): phylogenetic analysis, genera redefinition and new species descriptions, Journal of Natural History, DOI: 10.1080/00222933.2014.902142 To link to this article: http://dx.doi.org/10.1080/00222933.2014.902142 PLEASE SCROLL DOWN FOR ARTICLE Taylor & Francis makes every effort to ensure the accuracy of all the information (the “Content”) contained in the publications on our platform. However, Taylor & Francis, our agents, and our licensors make no representations or warranties whatsoever as to the accuracy, completeness, or suitability for any purpose of the Content. Any opinions and views expressed in this publication are the opinions and views of the authors, and are not the views of or endorsed by Taylor & Francis. The accuracy of the Content should not be relied upon and should be independently verified with primary sources of information.
    [Show full text]
  • Animal Venom Components: New Approaches for Pain Treatment
    Approaches in Poultry, Dairy & Veterinary Sciences ApproachesAppro Poult Dairy in Poultry,& Vet Sci Dairy & CRIMSON PUBLISHERS C Wings to the Research Veterinary Sciences ISSN: 2576-9162 Mini Review Animal Venom Components: New Approaches for Pain Treatment Ana Cristina N Freitas and Maria Elena de Lima* Departamento de Bioquímica e Imunologia, Brazil *Corresponding author: Maria E de Lima, Departamento de Bioquímica e Imunologia, Belo Horizonte, Minas Gerais, Brazil Submission: September 09, 2017; Published: November 06, 2017 Abbreviations: NSAID: Non-Steroidal Anti-Inflammatory Drugs; FDA: Food and Drug Administration; nAChRs: Nicotinic Acetylcholine Receptors; ASICs: Acid-Sensing Ion Channel Introduction This comment has the aim to be illustrative, highlighting some At the moment, there are a great number of animal toxins examples of venoms that have shown a great potential as analgesics. that are being studied for treatment or research of many different It is not our goal to write a review of this subject, considering it is disorders, including pain. The components isolated from animal not pertinent in a brief text like this. venoms gained this interest because of their usual high potency and selectivity in which they act on their molecular targets, such Nowadays there is a lot of concern and discussion about animal as ion channels or receptors [3]. Currently, a large number of welfare, since the role that animals play in human life is far beyond pharmaceutical companies are interested in the development of of being just our pets. Animals are very important as source of drugs based on toxins. One of the most successful cases, regarding pain treatment, was the development of Ziconotide (PRIALT).
    [Show full text]
  • Shk Toxin: History, Structure and Therapeutic Applications for Autoimmune Diseases
    ShK toxin: history, structure and therapeutic applications for autoimmune diseases WikiJournal of Science Search this Journal Search Open access • Publication charge free • Public peer review Submit Authors Reviewers Editors About Journal Issues Resources CURRENT Editorial In preparation guidelines Upcoming This is an unpublished pre-print. It is undergoing peer review. articles Authors: Shih Chieh Chang, Saumya Bajaj, K. George Chandy Ethics statement This pre-print is undergoing public peer review Laboratory of Molecular Physiology, Infection Immunity Theme, Lee Kong Chian School of Medicine, Nanyang Technological Bylaws University, Singapore First submitted: 04 January 2018 Financials Author correspondence: [email protected] Last updated: 05 January 2018 Contact Reviewer comments Last reviewed version Abstract Stichodactyla toxin (ShK) is a 35-residue basic peptide from the sea anemone Stichodactyla helianthus that blocks a number of potassium channels. An analogue of ShK called ShK-186 or Dalazatide is in human trials as Licensing: This is an open access article distributed under the Creative a therapeutic for autoimmune diseases. Commons Attribution License, which permits unrestricted use, distribution, and reproduction, provided the original author and source are credited. Key words: ShK peptide, autoimmune diseases, T cells, Kv1.3, ShK domains History Contents Stichodactyla helianthus is a sea anemone of the family Stichodactylidae. Abstract Helianthus comes from the Greek words Helios meaning sun, and anthos meaning History flower. S. helianthus is also referred to as the 'sun anemone'. It is sessile and uses potent neurotoxins for defense against its primary predator, the spiny lobster. The Structure venom contains, among other components, numerous ion channel-blocking Phylogenetic relationships of ShK and ShK domains peptides.
    [Show full text]
  • Design of a Truncated Cardiotoxin‑I Analogue with Potent Insulinotropic
    Design of a Truncated Cardiotoxin‑I Analogue with Potent Insulinotropic Activity Thi Tuyet Nhung Nguyen, Benjamin Folch, Myriam Letourneau, Nam Hai Truong, Nicolas Doucet, Alain Fournier, David Chatenet To cite this version: Thi Tuyet Nhung Nguyen, Benjamin Folch, Myriam Letourneau, Nam Hai Truong, Nicolas Doucet, et al.. Design of a Truncated Cardiotoxin‑I Analogue with Potent Insulinotropic Activity. Journal of Medicinal Chemistry, American Chemical Society, 2014, 57 (6), pp.2623-33. 10.1021/jm401904q. hal-01177382 HAL Id: hal-01177382 https://hal.archives-ouvertes.fr/hal-01177382 Submitted on 14 Sep 2015 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Design of a Truncated Cardiotoxin-I Analogue with Potent Insulinotropic Activity Thi Tuyet Nhung Nguyen†‡§, Benjamin Folch†∥⊥, Myriam Létourneau†§, Nam Hai Truong‡, Nicolas Doucet†∥⊥, Alain Fournier*†§, and David Chatenet*†§ † INRS−Institut Armand-Frappier, Université du Québec, 531 Boulevard des Prairies Ville de Laval, Québec H7 V 1B7, QuébecCanada ‡ Vietnam Academy of Science and Technology, Institute
    [Show full text]
  • Versatile Spider Venom Peptides and Their Medical and Agricultural Applications
    Accepted Manuscript Versatile spider venom peptides and their medical and agricultural applications Natalie J. Saez, Volker Herzig PII: S0041-0101(18)31019-5 DOI: https://doi.org/10.1016/j.toxicon.2018.11.298 Reference: TOXCON 6024 To appear in: Toxicon Received Date: 2 May 2018 Revised Date: 12 November 2018 Accepted Date: 14 November 2018 Please cite this article as: Saez, N.J., Herzig, V., Versatile spider venom peptides and their medical and agricultural applications, Toxicon (2019), doi: https://doi.org/10.1016/j.toxicon.2018.11.298. This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. ACCEPTED MANUSCRIPT MANUSCRIPT ACCEPTED ACCEPTED MANUSCRIPT 1 Versatile spider venom peptides and their medical and agricultural applications 2 3 Natalie J. Saez 1, #, *, Volker Herzig 1, #, * 4 5 1 Institute for Molecular Bioscience, The University of Queensland, St. Lucia QLD 4072, Australia 6 7 # joint first author 8 9 *Address correspondence to: 10 Dr Natalie Saez, Institute for Molecular Bioscience, The University of Queensland, St. Lucia QLD 11 4072, Australia; Phone: +61 7 3346 2011, Fax: +61 7 3346 2101, Email: [email protected] 12 Dr Volker Herzig, Institute for Molecular Bioscience, The University of Queensland, St.
    [Show full text]
  • FERNANDO HITOMI MATSUBARA.Pdf
    UNIVERSIDADE FEDERAL DO PARANÁ Setor de Ciências Biológicas Departamento de Biologia Celular FERNANDO HITOMI MATSUBARA CLONAGEM E EXPRESSÃO HETERÓLOGA DE UM PEPTÍDEO DA FAMÍLIA DAS NOTINAS PRESENTE NO VENENO DA ARANHA MARROM (Loxosceles intermedia) CURITIBA 2011 FERNANDO HITOMI MATSUBARA CLONAGEM E EXPRESSÃO HETERÓLOGA DE UM PEPTÍDEO DA FAMÍLIA DAS NOTINAS PRESENTE NO VENENO DA ARANHA MARROM (Loxosceles intermedia) Dissertação apresentada ao Programa de Pós- Graduação em Biologia Celular e Molecular, Departamento de Biologia Celular, Setor de Ciências Biológicas, Universidade Federal do Paraná, como parte das exigências para a obtenção do título de Mestre em Biologia Celular e Molecular Orientador: Prof. Dr. Silvio Sanches Veiga a a Co-orientadora: Prof . Dr . Olga Meiri Chaim CURITIBA 2011 Aos meus pais pela oportunidade que me concederam de poder me dedicar integralmente aos estudos. Pelo apoio incondicional e generosidade constante. Muito Obrigado! AGRADECIMENTOS Ao meu orientador, Prof. Dr. Silvio Sanches Veiga, por todos os ensinamentos, incentivos e confiança nesses 2 anos. Por proporcionar a oportunidade de me integrar ao Laboratório de Matriz Extracelular e Biotecnologia de Venenos e conviver com um grupo especial de pessoas. À minha co-orientadora, Profa Dra Olga Meiri Chaim, por ser um exemplo de competência e dedicação. Por ser generosa e, sobretudo, humana, aconselhando e motivando a todo instante. Muito obrigado! À Luiza Helena Gremski, pela prontidão em me ajudar em todos os experimentos. Por ser um exemplo de profissionalismo e disciplina. Muito obrigado por toda a paciência e disposição! À Profa. Dra. Andréa Senff Ribeiro, por todos os conselhos acadêmicos e pessoais. Pelos incentivos e momentos descontraídos! À Dilza Trevisan Silva, por todo o auxílio técnico e pela grande amizade! Por tornar todos os momentos divertidos e leves! Pelo companheirismo em absolutamente todas as horas! À Valéria Pereira Ferrer, por todo o auxílio técnico e pela grande amizade! Por ser exemplo de conduta ética e pela paciência.
    [Show full text]
  • Bioactive Mimetics of Conotoxins and Other Venom Peptides
    Toxins 2015, 7, 4175-4198; doi:10.3390/toxins7104175 OPEN ACCESS toxins ISSN 2072-6651 www.mdpi.com/journal/toxins Review Bioactive Mimetics of Conotoxins and other Venom Peptides Peter J. Duggan 1,2,* and Kellie L. Tuck 3,* 1 CSIRO Manufacturing, Bag 10, Clayton South, VIC 3169, Australia 2 School of Chemical and Physical Sciences, Flinders University, Adelaide, SA 5042, Australia 3 School of Chemistry, Monash University, Clayton, VIC 3800, Australia * Authors to whom correspondence should be addressed; E-Mails: [email protected] (P.J.D.); [email protected] (K.L.T.); Tel.: +61-3-9545-2560 (P.J.D.); +61-3-9905-4510 (K.L.T.); Fax: +61-3-9905-4597 (K.L.T.). Academic Editors: Macdonald Christie and Luis M. Botana Received: 2 September 2015 / Accepted: 8 October 2015 / Published: 16 October 2015 Abstract: Ziconotide (Prialt®), a synthetic version of the peptide ω-conotoxin MVIIA found in the venom of a fish-hunting marine cone snail Conus magnus, is one of very few drugs effective in the treatment of intractable chronic pain. However, its intrathecal mode of delivery and narrow therapeutic window cause complications for patients. This review will summarize progress in the development of small molecule, non-peptidic mimics of Conotoxins and a small number of other venom peptides. This will include a description of how some of the initially designed mimics have been modified to improve their drug-like properties. Keywords: venom peptides; toxins; conotoxins; peptidomimetics; N-type calcium channel; Cav2.2 1. Introduction A wide range of species from the animal kingdom produce venom for use in capturing prey or for self-defense.
    [Show full text]
  • Microprotein Hit Finding Library Uncovers Bee Venom PLA2 Inhibited by Spider Venom Emily Knight1,2 and Steven Trim1 1) Venomtech Limited, Sandwich, UK
    Microprotein Hit Finding Library Uncovers Bee Venom PLA2 Inhibited by Spider Venom Emily Knight1,2 and Steven Trim1 1) Venomtech Limited, Sandwich, UK. 2) Canterbury Christ Church University, Canterbury, UK. Introduction Phospholipase A2 (PLA2) enzymes are a large and diverse family of enzymes which are involved in the metabolism of potent inflammation mediators such as prostaglandins, leukotrienes and platelet activating factor (Huang et al., 1999). PLA2 enzymes have a role in inflammatory conditions such as atherosclerosis and rheumatoid arthritis. PLA2 inhibition is therefore considered an attractive target for therapeutic application in such inflammatory conditions. Toxic forms of PLA2 enzymes are present in many venoms, particularly those of Hymenoptera (Bees, Wasps and Ants). More recently, PLA2 enzymes have been discovered for the first time in venom of Theraphosidae (tarantula spiders) (Ferreira et al., 2016). PLA2 inhibitors have been documented in snake serum, presumably as protection against accidental envenomation (Dunn & Broady, 2001), but no such inhibitors have been discovered thus far in spiders. We therefore set out to investigate the potential presence of novel PLA2 inhibitors in theraphosid venom using the Targeted-Venom Discovery Array™ hit finding strategy. Venom libraries contain a diversity of pharmacological actives, including microproteins and peptides, which deliver hits on nearly all targets, especially those difficult to hit with small molecule libraries. Materials and Methods Venoms were selected to provide a wide coverage of genera of Theraphosidae (commonly known as tarantulas). EnzChek® Phospholipase A2 Assay Kit (Molecular Probes®, Invitrogen) was used to study PLA2 activity. The assays were performed in 384 well format using a reaction volume of 25 μl per well.
    [Show full text]
  • Morphology, Evolution and Usage of Urticating Setae by Tarantulas (Araneae: Theraphosidae)
    ZOOLOGIA 30 (4): 403–418, August, 2013 http://dx.doi.org/10.1590/S1984-46702013000400006 Morphology, evolution and usage of urticating setae by tarantulas (Araneae: Theraphosidae) Rogério Bertani1,3 & José Paulo Leite Guadanucci2 1 Laboratório Especial de Ecologia e Evolução, Instituto Butantan. Avenida Vital Brazil 1500, 05503-900 São Paulo SP, Brazil. E-mail: [email protected] 2 Laboratório de Zoologia de Invertebrados, Universidade Federal dos Vales do Jequitinhonha e Mucuri, Campus JK. Rodovia MGT 367, km 583, 39100-000 Diamantina, MG, Brazil. E-mail: [email protected] 3 Corresponding author. ABSTRACT. Urticating setae are exclusive to New World tarantulas and are found in approximately 90% of the New World species. Six morphological types have been proposed and, in several species, two morphological types can be found in the same individual. In the past few years, there has been growing concern to learn more about urticating setae, but many questions still remain unanswered. After studying individuals from several theraphosid species, we endeavored to find more about the segregation of the different types of setae into different abdominal regions, and the possible existence of patterns; the morphological variability of urticating setae types and their limits; whether there is variability in the length of urticating setae across the abdominal area; and whether spiders use different types of urticat- ing setae differently. We found that the two types of urticating setae, which can be found together in most theraphosine species, are segregated into distinct areas on the spider’s abdomen: type III occurs on the median and posterior areas with either type I or IV surrounding the patch of type III setae.
    [Show full text]
  • Siemens J and Hanack C Modulation of TRP Ion Channels by Venomous
    Modulation of TRP Ion Channels by Venomous Toxins Jan Siemens and Christina Hanack Contents 1 Introduction: Venom Biology .............................................................. 1120 2 Toxins of Venomous Organisms in Ion Channel Research and Medical Therapy ...... 1122 3 Toxins: Mode of Action ................................................................... 1124 4 Toxins Modulating TRPV1 Activity ...................................................... 1125 4.1 Vanillotoxins ......................................................................... 1125 4.2 Double-Knot Toxin .................................................................. 1127 5 Additional TRPV1-Mediated Toxin Effects .............................................. 1129 6 Toxins Affecting Other TRPs .............................................................. 1131 6.1 TRPV6 ................................................................................ 1132 6.2 TRPA1 ................................................................................ 1132 6.3 TRPCs ................................................................................ 1133 7 Discussion and Outlook .................................................................... 1133 References ..........................................................................................1136 Abstract Venoms are evolutionarily fine-tuned mixtures of small molecules, peptides, and proteins—referred to as toxins—that have evolved to specifically modulate and interfere with the function of diverse molecular targets
    [Show full text]
  • Conus Venom Peptide Pharmacology
    1521-0081/12/6402-259–298$25.00 PHARMACOLOGICAL REVIEWS Vol. 64, No. 2 Copyright © 2012 by The American Society for Pharmacology and Experimental Therapeutics 5322/3751766 Pharmacol Rev 64:259–298, 2012 ASSOCIATE EDITOR: ANNETTE C. DOLPHIN Conus Venom Peptide Pharmacology Richard J. Lewis, Se´bastien Dutertre, Irina Vetter, and MacDonald J. Christie Institute for Molecular Bioscience, the University of Queensland in St. Lucia, Brisbane, Queensland, Australia (R.J.L., S.D., I.V.); and Discipline of Pharmacology, the University of Sydney, Sydney, New South Wales, Australia (M.J.C.) Abstract ................................................................................ 260 I. Introduction............................................................................. 260 II. ␻-Conotoxin inhibitors of voltage-gated calcium channels .................................... 263 A. Subtype selectivity ................................................................... 264 B. Structure-activity relationships ........................................................ 266 C. Calcium channel inhibition by conotoxins in pain management ........................... 267 II. Conotoxins interacting with voltage-gated sodium channels .................................. 269 Downloaded from A. ␮-Conotoxin inhibitors of voltage-gated sodium channels ................................. 271 B. ␮O-Conotoxin inhibitors of voltage-gated sodium channels................................ 272 C. Other conotoxin inhibitors of voltage-gated sodium channels.............................
    [Show full text]